CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Phonak Audeo hearing aid +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04953390
NCT04953390N/ACompleted

Evaluating Benefits of Hearing Aid Microphone Directionality Technologies on Spatial Awareness and Speech Intelligibility

Sonova AG·interventional·Posted Jul 8, 2021·Updated Nov 9, 2022

In Brief

A clinical study evaluating Phonak Audeo hearing aid and Phonak hearing aid with multiple directionality settings, adjustable via a mobile app for Hearing Loss. Completed, enrolled 19 participants across 1 site.

Detailed Summary

This study will evaluate the impact of hearing aid microphone directionality technologies and settings on speech understanding in noise for experienced hearing aid users. It will also evaluate the participant's spatial awareness of sounds using these different hearing aid microphone directionality technologies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 8, 2021
Enrollment StartMay 3, 2021
Primary CompletionJul 2, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.0 years ago

Interventions

Phonak Audeo hearing aiddevice

Commercially available hearing aid with three different microphone settings: DIR1, DIR2, and DIR3

Phonak hearing aid with multiple directionality settings, adjustable via a mobile appdevice

Commercially available hearing aid with multiple directionality settings which will be adjustable by user via a mobile app during a home trial period.